Unleashing Brazil-Switzerland connections for Health innovation – Lausanne

Join us for an informative session about opportunities in the Health ecosystem in Brazil

Designed by kjpargeter / Freepik

Event Details


CHUV Lausanne
Rue du Bugnon 21, Lausanne, BH08 - Auditoire Charlotte Olivier, Lausanne, Lausanne Switzerland


September 24, 2019 from 8:00 pm to 10:00 pm Europe/Zurich (UTC+01:00)


Free admission

Join us for an informative session about opportunities in the Health ecosystem in Brazil, followed by a networking session at CHUV, Lausanne on the 24th of September at 5 pm to 7 pm (Rue du Bugnon 21, Lausanne, BH08 – Auditoire Charlotte Olivier).
Register here (free admission).

Who is it intended to?

Swiss startups, corporate heads of Innovation, managers of tech parks, researchers, investors, associations + anyone interested in building a network with Brazil in the Health sector.

Opportunities in the Brazilian Health ecosystem

Moderated panel discussion with Q&A session raising awareness and tackling potential synergies among Swiss and Brazilian players:

  • Landscape and opportunities in the Health Market: overview, facts & figures, go-to-market programs, access to investment;
  • Market Validation and Entry Camp strategies for Swiss startups in the Brazilian market;
  • Research collaborat​ions among Swiss and Brazilian institutions: best-practices of exchange.

Swiss Medtech Center is a meeting place for research, medicine, and industry to work on inter​disciplinary innovative projects in the fields of medtech and health-tech. Internal research & engineering resources are complemented with specialists from the national and international partner network to build perfectly adapted teams.

Fiocruz ​is one of the main biomedical research centers in Latin America. The Institute is responsible for a variety of scientific activities, always marked by the centenary commitment to do research allied to Education, to Reference in Health and to the research, and innovation maintenance of Biological Collections. Its Research Laboratories generate knowledge on several aspects in a variety of infection diseases – AIDS, tuberculosis, malaria, yellow fever, dengue fever, Zika, Chagas disease, leishmaniasis, leptospirosis, hepatitis, leprosy, meningitis, among many others – as well as chronic degenerative diseases such as muscular dystrophy and behavioral disorders. The Institute also takes part in environmental studies, prospecting of pharmaceuticals and development of new vaccines, diagnostic methods and therapeutic strategies.

Escolhares Project (Laboratory for Investigate Neurophysiology LINE at Unil) is a non-profit created by Swiss and Brazilian medical students to bring eye exams and eyeglasses to underprivileged school children of Rio de Janeiro, Brazil. Since its creation in 2017 more than 2’500 kids have benefited from Escolhares and over 300 pairs of glasses were given. To improve childrens’ access to eyecare, Escolhares also gathers data, develops research and implements social innovation.To accomplish these goals the organisation works together with the Fiocruz Research Institution in Brazil, the Brazilian Society of Ophthalmology and several local university hospitals. In Switzerland it is supported by the Unil International Relations department, as well as the Laboratory for Investigate Neurophysiology (LINE) at Unil and the Fondation Asile des Aveugles, among others.

techtools ventures ​is a healthcare innovation platform for startups that are looking to accelerate market entry; hospitals and corporations willing to improve their efficiency and mitigate risks; professional investors that seek to improve their investments.

swissnex Brazil is an initiative of Switzerland’s ​State Secretariat for Education, Research and Innovation (SERI)​, managed in cooperation with the ​Department of Foreign Affairs​. A public-private venture, we are part of a network of outposts also in the US, India and China. Along with individual science and technology counselors around the world, we work on behalf of Switzerland to expand education, research, and innovation.